93290-47-2 Usage
Purpose
Chemotherapy drug used in the treatment of certain types of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma.
Mechanism
Alkylating agent that damages the DNA of cancer cells, ultimately causing their death.
Administration
Taken orally in the form of capsules.
Side Effects
May include nausea, vomiting, fatigue, and a decreased white blood cell count.
Additional Information
Potent and important medication often used in combination with other cancer drugs or radiation therapy.
Check Digit Verification of cas no
The CAS Registry Mumber 93290-47-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,2,9 and 0 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 93290-47:
(7*9)+(6*3)+(5*2)+(4*9)+(3*0)+(2*4)+(1*7)=142
142 % 10 = 2
So 93290-47-2 is a valid CAS Registry Number.
93290-47-2Relevant academic research and scientific papers
Quinone Chemistry. Synthesis and Tautomerism of 4,7-Indazolequinones
Agarwal, Nand L.,Bohnstengel, Hans,Schaefer, Wolfram
, p. 825 - 832 (2007/10/02)
The reaction of 1 with hydrazines provided hydrazinium-4,7-dioxo-4,7-dihydroindazol-3-olates 2a-e and 4,7-indazolequinones 3f,g depending upon the nature of the substituent present in the reactants.Compounds 3a-g were obtained by treatment of 2a-e with so
